JAK Monotherapy Shows Efficacy in RA Review - Quiz - MDSpire

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.

  • By

  • Andrea Surnit

  • May 22, 2026

  • 4 min

Share

Original Source(s)

JAK Monotherapy Shows Efficacy in RA Review

  • by Andrea Surnit

  • May 22, 2026

Related Content

Obesity Not Associated With Worse Long-Term TAR Outcomes

A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.

Association of a data-driven nutrient risk score with incident rheumatoid arthritis in UK Biobank adults: a prospective cohort study

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.